VacciGuard Overview
- Year Founded
-
2007
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
VacciGuard General Information
Description
Developer of peptide-based platform technology to produce vaccines against infectious diseases and cancer. The company specializes in developing vaccines against several pathogens and therapeutic vaccines against devastating diseases such as cancer, and technology is based on peptides, such as carbohydrates, enabling the healthcare sector with effective vaccines by forming long-lasting Immunoglobulin antibodies.
Contact Information
Website
www.vacciguard.comCorporate Office
- PO Box: 20
- Misgav Business Park M.P.
- Misgav 20179
- Israel
Corporate Office
- PO Box: 20
- Misgav Business Park M.P.
- Misgav 20179
- Israel
VacciGuard Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 19-Nov-2024 | Completed | Out of Business | |||
| 3. Early Stage VC | 01-Jan-2010 | Completed | Startup | |||
| 2. Accelerator/Incubator | $550K | $550K | Completed | Startup | ||
| 1. Spin-Off | 01-Jan-2007 | Completed | Startup |
VacciGuard FAQs
-
When was VacciGuard founded?
VacciGuard was founded in 2007.
-
Where is VacciGuard headquartered?
VacciGuard is headquartered in Misgav, Israel.
-
What industry is VacciGuard in?
VacciGuard’s primary industry is Drug Discovery.
-
Is VacciGuard a private or public company?
VacciGuard is a Private company.
-
What is VacciGuard’s current revenue?
The current revenue for VacciGuard is .
-
How much funding has VacciGuard raised over time?
VacciGuard has raised $1.95M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process